SOUTH SAN FRANCISCO, Calif., Sept. 26, 2013 (GLOBE NEWSWIRE) -- Five Prime Therapeutics, Inc. (Nasdaq:FPRX) (Five Prime) announced today that the underwriters of its initial public offering have exercised their over-allotment option in full to purchase an additional 720,000 shares of common stock from Five Prime at the initial public offering price of $13.00 per share. With the exercise of the underwriters’ over-allotment option, the total number of shares sold in the offering was 5,520,000 shares, resulting in aggregate gross proceeds of $71.8 million, before underwriting discounts, commissions and expenses. All of such shares were sold by Five Prime.
Help employers find you! Check out all the jobs and post your resume.
